Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Catalyst Pharmaceuticals begin testing its orphan drug on first patients
December 15, 2016 Off

Catalyst Pharmaceuticals begin testing its orphan drug on first patients

By Dino Mustafić

Catalyst Pharmaceuticals, a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, has announced…

BD launches new prefillable glass syringe
December 15, 2016 Off

BD launches new prefillable glass syringe

By Dino Mustafić

BD has launched the BD Neopak 2.25 mL prefillable glass syringe, specifically designed for biopharmaceutical manufacturers that develop, manufacture and…

Lilly/Boehringer Ingelheim: A long-acting basal insulin available in U.S.
December 15, 2016 Off

Lilly/Boehringer Ingelheim: A long-acting basal insulin available in U.S.

By Dino Mustafić

Eli Lilly and Boehringer Ingelheim Pharmaceuticals have announced that Basaglar (insulin glargine injection 100 units/mL) is available by prescription in…

Survey: How would you improve pharmaceuticaldaily?
December 15, 2016 Off

Survey: How would you improve pharmaceuticaldaily?

By Dino Mustafić

As some of you might know, pharmaceuticaldaily.com has recently redesigned its website as it added some new features and has…

COMP gives positive opinion on Hansa Medical’s orphan drug
December 15, 2016 Off

COMP gives positive opinion on Hansa Medical’s orphan drug

By Dino Mustafić

Hansa Medical, a biopharmaceutical company focusing on novel immunomodulatory enzymes,  has announced that the Committee for Orphan Medicinal Products (COMP)…

Results of filgotinib Gilead’s study in Chron’s
December 15, 2016 Off

Results of filgotinib Gilead’s study in Chron’s

By Dino Mustafić

Galapagos has tested its filgotinib – JAK1 inhibitor – in a phase 2 study, for the patients with Chron’s disease, and…

NOXXON/Merck to study drugs combination in cancer treatment
December 15, 2016 Off

NOXXON/Merck to study drugs combination in cancer treatment

By Dino Mustafić

NOXXON Pharma N.V. has announced a collaboration with Merck & Co. (MSD), Inc, under which the two companies will collaborate…

Bioven gets green light for NSC cancer drug testing patient enrolment
December 15, 2016 Off

Bioven gets green light for NSC cancer drug testing patient enrolment

By Dino Mustafić

A cancer-focused drug-maker Bioven can now enrol patients in the USA in its international Phase III trial of EGF-PTI, in…

Kiadis Pharma starts a P I/II clinical trial for thalassemia treatment
December 15, 2016 Off

Kiadis Pharma starts a P I/II clinical trial for thalassemia treatment

By Dino Mustafić

Kiadis Pharma N.V., a clinical stage biopharmaceutical company developing innovative T-cell immunotherapy treatments for blood cancers and inherited blood disorders…

TiGenix raises $35.65M proceeds with NASDAQ IPO
December 15, 2016 Off

TiGenix raises $35.65M proceeds with NASDAQ IPO

By Dino Mustafić

A biopharmaceutical company TiGenix focused on allogeneic expanded stem cells, has raised $35.65 million gross proceeds from the sale of 2,300,000 American Depository…

Posts pagination

Previous 1 … 3,541 3,542 3,543 … 3,605 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine